Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive project
Zafeiris Louvaris, Daniel Langer, Santiago Giavedoni, Yogini Raste, Hans Van Remoortel, Eloisa Maria Gatti Regueiro, Frederick Wilson, Ioannis Vogiatzis, Nicholas Hopkinson, Roberto Rabinovich, Barry Peterson, Thierry Troosters
European Respiratory Journal 2011 38: p2157; DOI:
Zafeiris Louvaris
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Daniel Langer
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Santiago Giavedoni
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Yogini Raste
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Hans Van Remoortel
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Eloisa Maria Gatti Regueiro
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Frederick Wilson
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Ioannis Vogiatzis
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Nicholas Hopkinson
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Roberto Rabinovich
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Barry Peterson
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Thierry Troosters
Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Article Information
vol. 38 no. Suppl 55
Published By
Print ISSN
Online ISSN
History
- Published online September 27, 2022.
Copyright & Usage
© 2011 ERS
Author Information
- Zafeiris Louvaris,
- Daniel Langer,
- Santiago Giavedoni,
- Yogini Raste,
- Hans Van Remoortel,
- Eloisa Maria Gatti Regueiro,
- Frederick Wilson,
- Ioannis Vogiatzis,
- Nicholas Hopkinson,
- Roberto Rabinovich,
- Barry Peterson and
- Thierry Troosters
- Department of Critical Care Medicine and Pulmonary Services, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium Physical Therapy Department, University of Federal de São Carlos (UFSCar), Sao Paolo, Brazil Respiratory Medicine, NIHR, Respiratory Disease Biomedical Research, Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom Respiratory Medicine, ELEGI Colt Laboratories, University of Edinburgh, Edinburgh, United Kingdom Pfizer Global Research and Development, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom
Article usage
Altmetrics
Vol 38 Issue Suppl 55
Table of Contents
Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive project
Zafeiris Louvaris, Daniel Langer, Santiago Giavedoni, Yogini Raste, Hans Van Remoortel, Eloisa Maria Gatti Regueiro, Frederick Wilson, Ioannis Vogiatzis, Nicholas Hopkinson, Roberto Rabinovich, Barry Peterson, Thierry Troosters
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2157;
Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive project
Zafeiris Louvaris, Daniel Langer, Santiago Giavedoni, Yogini Raste, Hans Van Remoortel, Eloisa Maria Gatti Regueiro, Frederick Wilson, Ioannis Vogiatzis, Nicholas Hopkinson, Roberto Rabinovich, Barry Peterson, Thierry Troosters
European Respiratory Journal Sep 2011, 38 (Suppl 55) p2157;